Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Upgrades Warnings On Four Of Seven Drugs Flagged In Vioxx Testimony

Dec 06 2004

• By The Pink Sheet

Related Content

AstraZeneca Crestor Ad Defends Safety, Re-Asserts Superiority Claims

Nov 29 2004

SMART-er Isotretinoin Risk Management Program To Be Operated By Covance

Nov 29 2004

Celebrex Long-Term Safety Monitoring Results Reassure FDA

Nov 08 2004

Crestor, Serevent Safety Issues Push Vioxx Out Of Spotlight In Senate Hearing

Nov 22 2004

FDA Talking Tough On DTC: Is Viagra Letter First Of Many?

Nov 22 2004

Aventis Arava Adds Physical Function Claim, Bolded Liver Safety Warning

Jun 23 2003

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window